KRAS CODON 61 MUTATION DETECTION, TISSUE
KRAS codon 61 mutation is commonly found in certain cancers, such as colon and lung cancer. This test aids in understanding the genetic profile of the tumor and predicting response to targeted therapies.
KRAS CODON 61 MUTATION DETECTION, TISSUE Test in Mangaluru Overview
No special preparations needed
- Preliminary Report
- Kras Codon 61 Mutation
- Block Identification Number
- Clinical Details
The KRAS Codon 61 Mutation Detection Test identifies mutations in codon 61 of the KRAS gene, which may indicate resistance to certain cancer therapies, especially in colorectal and lung cancers.
This test is recommended for:
- Patients with colorectal cancer or non-small cell lung cancer (NSCLC).
- Individuals being considered for targeted therapies such as EGFR inhibitors.
- Cancer patients who require mutation profiling for treatment planning.
A tissue sample or liquid biopsy is analyzed using PCR or next-generation sequencing (NGS) to detect codon 61 mutations in the KRAS gene.
- Mutant Result: Presence of a mutation, indicating potential resistance to EGFR-targeted therapies.
- Wild-Type Result: No mutation, suggesting possible eligibility for targeted therapies.
Detecting KRAS mutations guides personalized treatment strategies, ensuring appropriate therapeutic interventions.
Test code
RD1315
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Tissue | Others | 1 NOS |
Specimen stability information
Tissue
Collection instructions
Site Of Biopsy & Clinical Details Mandatory If Tissue Recd.
Specimen rejection criteria
Test run frequency
Every Day TIME - 09:30
Turn around time
7 Working Days
Performing locations
Department
- Advanced Molecular Diagnostics R&d
CPT and Loinc codes
Package price
₹5500
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestKRAS CODON 61 MUTATION DETECTION, TISSUE
₹5500